-
Making Informed Consent Accessible
Confusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Facts and Stats
Rules for Healthy LivingUpdated guideline reinforces the role of plant-based foods and heart-pumping activities for cancer survivors.
by Thomas Celona
-
Q&A
Stay Engaged in LifeJournalist Helen Epstein’s memoir provides a candid account of nurturing her passions during treatment, even as the world shuttered its doors during the pandemic.
by Marci A. Landsmann
-
Survivor Profile
A Recovery MindsetResearcher and esophageal cancer survivor Laurie Betts leans into past lessons learned, including the value of service to others, to get through cancer.
by Lindsey Konkel Neabore
-
The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
Survivor Profile
Control What You CanBusiness leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
-
Survivor Profile
Grinding Through ItConnor Joe’s grit and determination helped him return to major league baseball after surgery and chemotherapy for testicular cancer that had spread to his lung.
by Marci A. Landsmann
-
Coping With Chemo Brain
Many cancer patients have problems with memory or thinking that can linger for years after treatment. The cause is a mystery, but new tactics are helping many people cope with its effects.
by Stephen Ornes
-
Forward Look
Coordination of CarePilot program emphasizes standards to streamline patient care.
by Carolyn Bernhardt
-
Need a Ride?
Cancer center expands pilot program to provide transportation for patients to get to appointments.
by Karen Blum
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff